IMMUNOME Trademark
Trademark Overview
On Monday, September 30, 2024, a trademark application was filed for IMMUNOME with the United States Patent and Trademark Office. The USPTO has given the IMMUNOME trademark a serial number of 98778646. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, May 20, 2025. This trademark is owned by Immunome, Inc.. The IMMUNOME trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations and substances for the treatment of oncological related diseases and disorders
Biotechnology services, namely, development of monoclonal antibodies and antibody drug conjugates; pharmaceutical, medical, scientific, biopharmaceutical and biotechnology research and development; drug discovery services; providing medical and scientific research information in the field of medicine and pharmaceuticals
General Information
| Serial Number | 98778646 |
| Word Mark | IMMUNOME |
| Filing Date | Monday, September 30, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Tuesday, May 20, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, June 10, 2025 |
Trademark Statements
| Description of Mark | The mark consists of the wording "IMMUNOME" in a stylized font below three drops positioned in a triangular pattern. A stylized triangle separates each drop. |
| Goods and Services | Pharmaceutical preparations and substances for the treatment of oncological related diseases and disorders |
| Section 2(f) Limitation Statement | as to "IMMUNOME". |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Biotechnology services, namely, development of monoclonal antibodies and antibody drug conjugates; pharmaceutical, medical, scientific, biopharmaceutical and biotechnology research and development; drug discovery services; providing medical and scientific research information in the field of medicine and pharmaceuticals |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 30, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 30, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Immunome, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Bothell, WA 98011 |
Trademark Events
| Event Date | Event Description |
| Monday, September 30, 2024 | NEW APPLICATION ENTERED |
| Friday, April 4, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, April 7, 2025 | ASSIGNED TO EXAMINER |
| Friday, April 4, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, April 18, 2025 | NON-FINAL ACTION WRITTEN |
| Friday, April 18, 2025 | NON-FINAL ACTION E-MAILED |
| Friday, April 18, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, April 21, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Monday, April 21, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Monday, April 21, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, May 7, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, April 21, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
